Immunodetection and clinico-pathological correlates of two tumour growth regulators in laryngeal carcinoma.
Activation of telomerase, present in the vast majority of all human cancers, is associated with elongation of chromosomal telomeres and consequent cell immortalization. Telomere length homeostasis is a dynamic process governed by the negative feedback mechanism of the telomeric repeat binding factor 1 (TRF1) which inhibits the action of telomerase in telomerase-positive cells. In an attempt to investigate markers of tumour growth as possible prognostic indicators in laryngeal cancer, we studied the expression of TRF1 and of the proliferation marker Ki67 on 96 invasive squamous carcinomas of the larynx. A standard three step immunoperoxidase staining method was applied on paraffin sections incubated with appropriate polyclonal antibodies. The percentages of Ki67- and TRF1-immunopositive cancerous cells were calculated by image analysis. Univariate and multivariate statistical analysis of the staining results were performed in order to detect any association of the examined immunomarkers with the tumours' classical clinicopathological variables including nuclear morphometric features as well as with patients' disease-free survival. Ki67 immunostaining was positively linked with advanced patients' age, nodal involvement as well as presence of early recurrence. No relation was found between proliferative fraction and TRF1 immunoexpression. TRF1 was expressed in 55.2% of all cases and was positively linked only to tumour size. Multivariate statistical analysis revealed the presence of lymph nodal metastasis and Ki67 immunopositivity index > or = 20% as significant predictors of relapse. Increased Ki67 immunostaining appears to be a promising marker of tumour aggressiveness in laryngeal cancer. After one point at the tumour's natural history, the maintenance of tumour growth does not seem to depend on cell proliferation but on TRF1 immunoexpression. Whether the latter can be used for the identification of immortalized cells in every-day practice is worth investigating.
Lazaris
A Ch
ACh
Department of Pathology, School of Medicine, The National and Capodistrian University of Athens, Greece. alazaris@cc.uoa.gr
Rigopoulou
A
A
Tseleni-Balafouta
S
S
Kavantzas
N
N
Thimara
I
I
Zorzos
H S
HS
Eutychiadis
C A
CA
Petraki
K
K
Kandiloros
D
D
Davaris
P
P
D000293:Adolescent; D000328:Adult; D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000378:metabolism* / Q000473:pathology*; D002648:Child; D004268:DNA-Binding Proteins / Q000378:metabolism*; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D019394:Ki-67 Antigen / Q000096:biosynthesis; D007822:Laryngeal Neoplasms / Q000378:metabolism* / Q000473:pathology*; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D016612:Paraffin Embedding; D011237:Predictive Value of Tests; D011379:Prognosis; D013534:Survival; D016615:Telomere / Q000378:metabolism; D035321:Telomeric Repeat Binding Protein 1; D016707:Tissue Fixation
D004268:DNA-Binding Proteins; D019394:Ki-67 Antigen; D035321:Telomeric Repeat Binding Protein 1